Prof Dave Haddleton's group collaborated with scientists at Unilever to develop SweatSense - a new technology to test deodorant performance through sweat mapping. Read moreLink opens in a new window.

100% of Warwick Chemistry’s research recognised as world-leading or internationally excellent by the Research Excellence Framework 2021Link opens in a new window

Prof Matthew Gibson was invited to attend the Royal Society’s Science of COVID invitation-only conference this week. Read more

The Medical Schools Council today published a report showcasing the work from UK Universities during the COVID-19 Pandemic, including from the GibsonGroup

The GibsonGroup have published their latest work on using glycans as alternative probes in rapid diagnostics, working with UHCW and industry

In November 2018, the Monash Warwick Alliance funded Chemists to develop and identify cost-effective, highly active, selective and stable catalysts. Check their progress...

Researchers at the Universities of Warwick and Nottingham have received EPSRC funding to launch a ground-breaking research programme for global specialist chemical manufacturer, Lubrizol.

The University of Warwick spin-out company, CryoLogyx, has received a further investment from Oxford Technology Management and private investors, alongside £300k from InnovateUK.

A new biotechnology company, CryoLogyx, has been spun-out from the department, supported from a grant from InnovateUK. Cryologyx will be led by Dr Tom Congdon (A UoW UG and PG alumus) and will exploit technology developed by the GibsonGroup. Cryologyx will use innovative macromolecular (polymeric) cryoprotectants to protect biological samples, including cells used in therapy, diagnostics and drug discovery.

Read the news story here and more details will be released soon.